US 8506961
Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 8506961 (Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K47/6841, A61P